Coenzyme Q10
Ubiquinone / Ubiquinol (CoQ10) for Male Fertility
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not FDA approved for fertility; sold as a dietary supplement
Reference only. Not medical advice.
What can go wrong
Generally well tolerated; mild GI upset, headache, and insomnia are reported. CoQ10 can modestly lower blood pressure and may reduce warfarin's anticoagulant effect (structural similarity to vitamin K), so anticoagulated patients should be cautious. It is not a substitute for evaluating and treating correctable causes of infertility such as varicocele or endocrine disorders.
This is something to take to a clinician. The Atlas can tell you what is known about coenzyme q10 in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Coenzyme Q10 is a lipid-soluble electron-transport-chain cofactor concentrated in the sperm midpiece, where it supports ATP production and quenches reactive oxygen species. It is the antioxidant with the most randomized data in idiopathic male infertility: Safarinejad's trials (2009 CoQ10 300 mg; 2012 ubiquinol 200 mg, n=228) reported gains in sperm concentration and motility, and meta-analyses find consistent improvements in sperm parameters. Crucially, no adequately powered trial has shown that CoQ10 increases live births, and the 2020 MOXI antioxidant trial found no fertility benefit for a multi-antioxidant regimen.
The best-studied antioxidant for sperm parameters, still short of proving it makes babies.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
CoQ10 shuttles electrons between complexes I/II and III of the mitochondrial respiratory chain, driving oxidative phosphorylation that powers sperm flagellar motility. It also functions as a chain-breaking antioxidant in sperm membranes, limiting lipid peroxidation that damages the highly polyunsaturated sperm plasma membrane and sperm DNA. Seminal-plasma CoQ10 concentration correlates with motility, which is the biological rationale for supplementation.
The endpoint the marketing skips
Semen parameters are surrogate markers. A supplement can raise sperm concentration and motility on a lab report without changing the outcome couples actually want, a baby. The 2019 Cochrane review of antioxidants for subfertile men rated the evidence for live birth as low quality, and the NIH-funded MOXI randomized trial (2020) of a combined antioxidant formulation found no improvement in semen parameters or pregnancy at 6 months. CoQ10's parameter data are real; the reproductive payoff is not established.
What people get wrong
Often saidCoQ10 fixes male infertility
ActuallyIt improves surrogate semen metrics in some trials but has not been shown to increase live births; couples should still pursue a full andrology workup.
Often saidUbiquinol is dramatically better than ubiquinone
ActuallyUbiquinol has higher measured bioavailability, but head-to-head fertility-outcome superiority is not established; both raised seminal CoQ10 in trials.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Set against the alternatives
Within the fertility-antioxidant field, CoQ10 has more randomized data than L-carnitine, NAC, or lycopene, but all share the same unresolved live-birth question. It is often stacked with carnitine, selenium, zinc, and folate in combination products, which makes attributing any effect to CoQ10 alone difficult.
What we do not know
- Does CoQ10 raise live-birth rates in adequately powered trials?
- Which sperm phenotypes (e.g., high DNA fragmentation) actually respond?
- Is ubiquinol clinically superior to ubiquinone for fertility, or only on absorption metrics?
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
Most CoQ10 is produced by yeast fermentation (Kaneka is the dominant ubiquinol supplier). Bioavailability varies widely by formulation; softgel/oil-suspension and solubilized forms absorb better than dry powder, a genuine quality differentiator buyers cannot see on the label.
At a glance
- Typical dose
- 200-300 mg/day
- Forms
- Ubiquinone (oxidized) / Ubiquinol (reduced)
- Endpoint gap
- Improves semen metrics, not proven live births
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Coenzyme Q10. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Safarinejad, J Urol (CoQ10 300 mg, 26 wk)2009
Improved sperm density and motility vs placebo in idiopathic infertility
Safarinejad, ubiquinol 200 mg (n=228)2012
Increased sperm motility and seminal ubiquinol; no live-birth endpoint
Cochrane antioxidants for subfertile men2019
Low-quality evidence; possible increase in live birth across antioxidants, high uncertainty
MOXI antioxidant RCT (NICHD)2020
No improvement in semen parameters or pregnancy from combined antioxidant regimen